15.12.2020 wykonaliśmy w Europie pierwsze zabiegi angioplastyki wieńcowej (PCI) z zastosowaniem najnowszej generacji robota sterującego ruchami cewników, prowadników i systemami dostarczania stentów. Kolejna rewolucja w kardiologii interwencyjnej i kardiologii cyfrowej XXI wieku.

"Coronary sinus narrowing for the treatment of refractory angina A multi-center prospective open-label clinical study (The REDUCER-I study)" by Stefan Verheye et al. #EAPCI bit.ly/3gR4kPm

"Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system" by Stefan Verheye et al. #EAPCI bit.ly/2R8qqR8

Trending in EuroIntervention - January 2021 Edition

Shock the rock!! 💪🏼 @MCHcardio #RadialFirst

Wonderful weekend of bench-testing with Dariusz Dudek EAPCIPresident learning tips, tricks and new techniques! Arif Khokhar Rossella Ruggiero @kailashGarhwalR Francesco Giannini

Końcem stycznia 2021 polsko-włoski zespół badawczy wykonał badania dostępu do tętnic wieńcowych po założeniu zastawek TAVI oraz zastawek TAVI w zdegenerowana zastawkę chirurgiczna. Grupa badawcza przedstawi publikacje pokazujące techniki przedoperacyjnego planowania zabiegów.

Gianluca Campo FIRE Trial Javier Escaned Tebaldi Matteo Carlo Penzo Carlo Tumscitz Francesco Giannini Antonio Colombo antonio mangieri PCRonline 🫀 European Society of Cardiology EuroIntervention Allen Jeremias Evandro Martins F. MD Gregg W. Stone MD Alessandro Sticchi Rossella Ruggiero Alberto Cereda

Congratulations for a great collaborative effort led by Francesco Giannini Marco Toselli Alberto Cereda Alessandro Sticchi

Our letter in @Eurointervention about pitfalls in functional capacity estimation of chronic angina population. eurointervention.pcronline.com/article/letter… Francesco Giannini #angina #eurointervention #EHJ #chronicangina #reducer #coronaryarterydisease #henrydunanthospitalcenter

Coronary Sinus Reducer to Improve Angina: -n=15 -greater ischemia improvement with smaller CS sizes -suggests mechanism of Reducer non-responsiveness in 15-30% of pts onlinelibrary.wiley.com/doi/full/10.10… Follow @CCIJournal, facebook.com/CCIJournal Official Journal of SCAI

Parte il Journal Club del GISE Young in collaborazione con i fellows del MCH di Cotignola. Ogni venerdì mattina un membro GISE Young presenterà online un paper pubblicato sulle top riviste. Primo appuntamento venerdì 30 aprile ore 7.30, link zoom via mailing list GISE Young.

Novel techniques for coronary access learnt from bench testing! Stay tuned for the manuscript Francesco Giannini EAPCIPresident Rossella Ruggiero @kailashGarhwalR Carlo Tumscitz Marco Toselli antonio mangieri EuroIntervention BostonSci Cardiology

Just Accepted Article: A computed tomography-based, three-dimensional multi-parametric imaging approach to evaluate coronary access following ACURATE Neo implantation in a degenerated surgical bioprosthesis. ow.ly/6fSs50FWTn3

Horizontal aorta? -> consider valve design show Francesco Gallo Francesco Giannini and colleagues

Arif Khokhar #EuroPCR2022 #winner Jonathan Curio Francesco Giannini Congratulations to Arif and all the team for demonstrating coronary access after Valve in Valve with ACURATE neo: ex vivo analysis

Join us today for an exciting session on aortic stenosis lifetime management ❤️with a brand new #simulation approach 🤖and get hands on insights 📍BostonSci Cardiology Training Village 🕒 14:45 - 15:45 #EuroPCR 2024 🇫🇷 Arif Khokhar Francesco Giannini PCRonline 🫀 #TAVI #TAVR

✍️ Read a new #editorial in #CJC regarding an elegant bench study by Francesco Giannini and colleagues looking at coronary access following VIV #TAVR. Coronary access might be challenging and all THV platforms are different. onlinecjc.ca/article/S0828-…

Alessandro Beneduce ruicteles cardio Cláudio Guerreiro Jonathan Curio Francesco Giannini Profesor Dariusz Dudek - kardiolog vinayak bapat Miho.Fukui David Meier Radoslaw Parma Chris Cook AKODAD Myriam Manuel Santos João Silva Marques Alessandro Sticchi Boston Scientific EMEA - Cardiology TAVR Bot PCRonline 🫀

Francesco Giannini presenting the results of First-in-human experience with a novel self-expandable coronary sinus reducer for treating symptomatic epicardial and microvascular ischemic heart disease at #TCT2025 Cardiovascular Research Foundation VahatiCor Jean-Michel Paradis #CardioX #CardioTwitter #CardioEd